Bores GM - Search Results

1

Aminopyridine carbamic acid esters: synthesis and potential as acetylcholinesterase inhibitors and acetylcholine releasers.

Shutske GM, Tomer JD, Kapples KJ, Hrib NJ, Jurcak JG, Bores GM, Huger FP, Petko W, Smith CP. Shutske GM, et al. Among authors: bores gm. J Pharm Sci. 1992 Apr;81(4):380-5. doi: 10.1002/jps.2600810419. J Pharm Sci. 1992. PMID: 1501077

2

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.

Shutske GM, Pierrat FA, Kapples KJ, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL. Shutske GM, et al. Among authors: bores gm. J Med Chem. 1989 Aug;32(8):1805-13. doi: 10.1021/jm00128a024. J Med Chem. 1989. PMID: 2754707

3

(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.

Shutske GM, Pierrat FA, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL. Shutske GM, et al. Among authors: bores gm. J Med Chem. 1988 Jul;31(7):1278-9. doi: 10.1021/jm00402a002. J Med Chem. 1988. PMID: 3385720 No abstract available.

4

Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.

Fink DM, Bores GM, Effland RC, Huger FP, Kurys BE, Rush DK, Selk DE. Fink DM, et al. Among authors: bores gm. J Med Chem. 1995 Sep 1;38(18):3645-51. doi: 10.1021/jm00018a025. J Med Chem. 1995. PMID: 7658452

5

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW Jr, Davis L, Vargas HM. Bores GM, et al. J Pharmacol Exp Ther. 1996 May;277(2):728-38. J Pharmacol Exp Ther. 1996. PMID: 8627552

6

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM. Smith CP, et al. Among authors: bores gm. J Pharmacol Exp Ther. 1997 Feb;280(2):710-20. J Pharmacol Exp Ther. 1997. PMID: 9023283

7

Serotonergic activity of HP 184: does spontaneous release have a role?

Smith CP, Woods-Kettelberger AT, Corbett R, Chesson SM, Bores GM, Petko WW, Roehr JE, Kongsamut S. Smith CP, et al. Among authors: bores gm. Neurochem Res. 1996 May;21(5):575-83. doi: 10.1007/BF02527756. Neurochem Res. 1996. PMID: 8726966

8

Amyloid beta-peptides inhibit Na+/K+-ATPase: tissue slices versus primary cultures.

Bores GM, Smith CP, Wirtz-Brugger F, Giovanni A. Bores GM, et al. Brain Res Bull. 1998 Jul 15;46(5):423-7. doi: 10.1016/s0361-9230(97)00382-1. Brain Res Bull. 1998. PMID: 9739004

9

Besipirdine (HP 749) reduces schedule-induced polydipsia in rats.

Woods-Kettelberger AT, Smith CP, Corbett R, Szewczak MR, Roehr JE, Bores GM, Klein JT, Kongsamut S. Woods-Kettelberger AT, et al. Among authors: bores gm. Brain Res Bull. 1996;41(2):125-30. Brain Res Bull. 1996. PMID: 8879677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters